Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alfredo E Rodriguez

Showing results (31-40 of 59) with videos related to

Pageof 6
Sort By:
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|March 8, 2016
Second vs. First generation drug eluting stents in multiple vessel disease and left main stenosis: Two-year follow-up of the observational, prospective, controlled, and multicenter ERACI IV registryCarlos Haiek, Carlos Fernández-Pereira, Omar Santaera, et al.
JACC. Cardiovascular Imaging|September 19, 2009
Early assessment of myocardial viability by the use of delayed enhancement computed tomography after primary percutaneous coronary interventionGastón A Rodriguez-Granillo, Miguel A Rosales, Santiago Baum, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|May 11, 2010
Percutaneous coronary intervention with oral sirolimus and bare metal stents has comparable safety and efficacy to treatment with drug eluting stents, but with significant cost saving: long-term follow-up results from the randomised, controlled ORAR III (Oral Rapamycin in ARgentina) studyAlfredo E Rodriguez, Andrew Maree, Sonia Tarragona, et al.
Frontiers in Cardiovascular Medicine|June 3, 2024
Trends in primary percutaneous coronary intervention for the treatment of acute coronary ST-elevation myocardial infarction in Latin American countries: insights from the CECI consortiumAlfredo Matías Rodriguez-Granillo, Leonardo Solórzano, Gilberto Vladimir Pérez-Omaña, et al.
Journal of the American College of Cardiology|September 20, 2014
Long-term outcome of PCI versus CABG in insulin and non-insulin-treated diabetic patients: results from the FREEDOM trialGeorge D Dangas, Michael E Farkouh, Lynn A Sleeper, et al.
Atherosclerosis|December 3, 2014
ORAl iMmunosuppressive therapy to prevent in-Stent rEstenosiS (RAMSES) cooperation: a patient-level meta-analysis of randomized trialsSalvatore Cassese, Giuseppe De Luca, Flavio Ribichini, et al.
Journal of the American College of Cardiology|April 25, 2006
Oral rapamycin after coronary bare-metal stent implantation to prevent restenosis: the Prospective, Randomized Oral Rapamycin in Argentina (ORAR II) StudyAlfredo E Rodriguez, Juan F Granada, Máximo Rodriguez-Alemparte, et al.
JAMA|April 1, 2008
Comparison of angioplasty with infusion of tirofiban or abciximab and with implantation of sirolimus-eluting or uncoated stents for acute myocardial infarction: the MULTISTRATEGY randomized trialMarco Valgimigli, Gianluca Campo, Gianfranco Percoco, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|September 9, 2010
Efficacy and safety of a double-coated paclitaxel-eluting coronary stent: the EUCATAX trialAlfredo E Rodriguez, Cesar F Vigo, Alejandro Delacasa, et al.
JACC. Cardiovascular Interventions|January 22, 2011
Persistent coronary no flow after wire insertion is an early and readily available mortality risk factor despite successful mechanical intervention in acute myocardial infarction: a pooled analysis from the STRATEGY (Single High-Dose Bolus Tirofiban and Sirolimus-Eluting Stent Versus Abciximab and Bare-Metal Stent in Acute Myocardial Infarction) and MULTISTRATEGY (Multicenter Evaluation of Single High-Dose Bolus Tirofiban Versus Abciximab With Sirolimus-Eluting Stent or Bare-Metal Stent in Acute Myocardial Infarction Study) trialsMarco Valgimigli, Gianluca Campo, Patrizia Malagutti, et al.
Pageof 6

Showing results (31-40 of 59) with videos related to

Sort By:
Pageof 6
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|March 8, 2016
Second vs. First generation drug eluting stents in multiple vessel disease and left main stenosis: Two-year follow-up of the observational, prospective, controlled, and multicenter ERACI IV registryCarlos Haiek, Carlos Fernández-Pereira, Omar Santaera, et al.
JACC. Cardiovascular Imaging|September 19, 2009
Early assessment of myocardial viability by the use of delayed enhancement computed tomography after primary percutaneous coronary interventionGastón A Rodriguez-Granillo, Miguel A Rosales, Santiago Baum, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|May 11, 2010
Percutaneous coronary intervention with oral sirolimus and bare metal stents has comparable safety and efficacy to treatment with drug eluting stents, but with significant cost saving: long-term follow-up results from the randomised, controlled ORAR III (Oral Rapamycin in ARgentina) studyAlfredo E Rodriguez, Andrew Maree, Sonia Tarragona, et al.
Frontiers in Cardiovascular Medicine|June 3, 2024
Trends in primary percutaneous coronary intervention for the treatment of acute coronary ST-elevation myocardial infarction in Latin American countries: insights from the CECI consortiumAlfredo Matías Rodriguez-Granillo, Leonardo Solórzano, Gilberto Vladimir Pérez-Omaña, et al.
Journal of the American College of Cardiology|September 20, 2014
Long-term outcome of PCI versus CABG in insulin and non-insulin-treated diabetic patients: results from the FREEDOM trialGeorge D Dangas, Michael E Farkouh, Lynn A Sleeper, et al.
Atherosclerosis|December 3, 2014
ORAl iMmunosuppressive therapy to prevent in-Stent rEstenosiS (RAMSES) cooperation: a patient-level meta-analysis of randomized trialsSalvatore Cassese, Giuseppe De Luca, Flavio Ribichini, et al.
Journal of the American College of Cardiology|April 25, 2006
Oral rapamycin after coronary bare-metal stent implantation to prevent restenosis: the Prospective, Randomized Oral Rapamycin in Argentina (ORAR II) StudyAlfredo E Rodriguez, Juan F Granada, Máximo Rodriguez-Alemparte, et al.
JAMA|April 1, 2008
Comparison of angioplasty with infusion of tirofiban or abciximab and with implantation of sirolimus-eluting or uncoated stents for acute myocardial infarction: the MULTISTRATEGY randomized trialMarco Valgimigli, Gianluca Campo, Gianfranco Percoco, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|September 9, 2010
Efficacy and safety of a double-coated paclitaxel-eluting coronary stent: the EUCATAX trialAlfredo E Rodriguez, Cesar F Vigo, Alejandro Delacasa, et al.
JACC. Cardiovascular Interventions|January 22, 2011
Persistent coronary no flow after wire insertion is an early and readily available mortality risk factor despite successful mechanical intervention in acute myocardial infarction: a pooled analysis from the STRATEGY (Single High-Dose Bolus Tirofiban and Sirolimus-Eluting Stent Versus Abciximab and Bare-Metal Stent in Acute Myocardial Infarction) and MULTISTRATEGY (Multicenter Evaluation of Single High-Dose Bolus Tirofiban Versus Abciximab With Sirolimus-Eluting Stent or Bare-Metal Stent in Acute Myocardial Infarction Study) trialsMarco Valgimigli, Gianluca Campo, Patrizia Malagutti, et al.
Pageof 6